BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18791172)

  • 1. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation.
    Yang W; Li H; Chen PW; Alizadeh H; He Y; Hogan RN; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):273-80. PubMed ID: 18791172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro.
    Yang W; Chen PW; Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2518-25. PubMed ID: 18296654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity.
    Pinchuk IV; Saada JI; Beswick EJ; Boya G; Qiu SM; Mifflin RC; Raju GS; Reyes VE; Powell DW
    Gastroenterology; 2008 Oct; 135(4):1228-1237, 1237.e1-2. PubMed ID: 18760278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection.
    Wu YY; Lin CW; Cheng KS; Lin C; Wang YM; Lin IT; Chou YH; Hsu PN
    Clin Exp Immunol; 2010 Sep; 161(3):551-9. PubMed ID: 20646001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
    Ghiotto M; Gauthier L; Serriari N; Pastor S; Truneh A; Nunès JA; Olive D
    Int Immunol; 2010 Aug; 22(8):651-60. PubMed ID: 20587542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
    Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
    J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells.
    Pittet CL; Newcombe J; Antel JP; Arbour N
    Glia; 2011 May; 59(5):841-56. PubMed ID: 21360758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis.
    Mazanet MM; Hughes CC
    J Immunol; 2002 Oct; 169(7):3581-8. PubMed ID: 12244148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
    Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
    PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.